Concepedia

Naima Hammoudi

NH

14

Publications

722

Citations

12

H-Index

2012

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Beth Israel Deaconess Medical Center

The University of Texas Health Science Center at Houston

Harvard University

Sun Yat-sen University

Naima Hammoudi is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and cancer research.

Top concepts

MedicinePharmacologyCancer ResearchApoptosisPathologyCell DeathCell BiologyDrug DiscoveryPharmacotherapyChemical Biology

Publications per year

2012–2024

14

Publications

14

Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential

Hélène Pelicano, Wan Zhang, Jinyun Liu et al. · Breast Cancer Research · 2014 · 213 citations · Full text

SF2312 is a natural phosphonate inhibitor of enolase

Paul G. Leonard, Nikunj Satani, David S. Maxwell et al. · Nature Chemical Biology · 2016 · 97 citations · Full text

Medicine, Mechanism Of Action, Natural Phosphonate Inhibitor +5

An enolase inhibitor for the targeted treatment of ENO1-deleted cancers

Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi et al. · Nature Metabolism · 2020 · 95 citations · Full text

Medicine, Enolase Inhibitor, Pharmacology +5

Effective Killing of Leukemia Cells by the Natural Product OSW-1 through Disruption of Cellular Calcium Homeostasis

Celia Garcı́a-Prieto, Kausar Begam Riaz Ahmed, Zhao Chen et al. · Journal of Biological Chemistry · 2012 · 62 citations · Full text

Apoptosis, Cell Death, Leukemia Cells +19

Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism

Shuqiang Yuan, Yun‐Xin Lu, Jing Yang et al. · Stem Cell Research & Therapy · 2015 · 47 citations · Full text

Rows per page

1–5 of 14